ABPI publishes industry payments to health professionals and organizations
Trade group the Association of the British Pharmaceutical Industry (ABPI) has today published for the first time details of payments or benefits in kind - made to doctors, nurses and pharmacists, as well as other health professionals and healthcare organizations in the UK on a publicly accessible database - Disclosure UK ( www.disclosureuk.org.uk).
This new database, available to download on the ABPI website ( www.disclosureuk.org.uk), shows payments from 109 pharmaceutical companies in the UK (54 ABPI member companies and 55 non-member companies).
The data shows that in 2015, industry spent a total of £340.3 million ($456.0 million) on working with health professionals and organizations, of which £229.3 million (67%) is for activities related to the research and development of new medicines.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze